Life Science Emerging Growth Companies: Accounting for Your Funding - MassBio

Overview

MassBio
300 Technology Square
Suite 8
Cambridge, MA 02139
United States

Thursday, 30 January 2020 - 11:30am to 1:00pm

View Event Page

Details

Series A, SBIR/STTR, R01, BARDA, Venture Capital, Private Equity, SBA Loans, Private Investors – whatever way you choose to fund your business comes with specific accounting requirements. From negotiating indirect rates with the government to preparing quarterly financials and negotiating term sheets, you must understand your financial reporting obligations so your business can grow successfully and without penalty.

• Speakers: Taryn Bostjancic, CPA and Life Science Practice Leader at Withum, Brian LaCroix, CPA and Partner of Jameson & Co. LLC, Will Adams, CEO of Riparian Pharmaceuticals and David Raiser, CEO of Aldatu BioSciences

• Discuss the ins and outs of accounting for emerging growth companies based on their current funding and future funding goals

• First hand accounts from CEOs while they continue to build their businesses, specifically in the life science industry

RSVP Here.

Unable to make this date? Check out our other date for this event.